Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- After Battling Covid, Malaria And Dengue, Man Now Survives Deadly Snakebiteon November 23, 2020 at 4:50 am
After recovering from COVID-19, dengue and malaria, a man in India is currently recuperating from a potentially deadly snake bite. Ian Jones, a charity worker from Britain who has been living in India ...
- British man in India survives cobra bite after recovering from COVID-19, dengue, malariaon November 23, 2020 at 3:41 am
Apparently, a lot! A charity worker from Britain in India went through a lot. After surviving COVID-19, dengue, and malaria, Ian Jones did not expect any more hurdles. But then, he was bit by a deadly ...
- Protecting pregnant women and children from malaria in Sierra Leoneon November 21, 2020 at 8:29 pm
BBC Media Action is using expertise and insight from our response to the Ebola outbreak in Sierra Leone to reduce malaria among women of child bearing age and their children.
- After Malaria And Covid, British Man Survives Cobra Bite In Indiaon November 21, 2020 at 7:34 am
A British charity worker who survived coronavirus, dengue and malaria was recovering after a potentially deadly snake bite in western India's Rajasthan state. Ian Jones was bitten by an Indian cobra ...
- Lancaster University to help control the spread of invasive malaria mosquitoon November 20, 2020 at 3:17 pm
Lancaster University is involved in a major research project which aims to control the spread of an invasive malaria mosquito in Sudan and Ethiopia.
- Children as superspreaders of malariaon November 19, 2020 at 3:08 am
New research from Uganda offers a new opportunity to suppress the parasite in communities — and shows that eliminating the disease might be harder than previously thought.
- Young asymptomatic 'super spreaders' keep malaria viable by infecting local mosquitoeson November 18, 2020 at 9:14 am
Malaria researchers, working in an area of Uganda where infections have been dropping dramatically, discovered a small number of infected but asymptomatic school-age children can serve as stealth ...
- Children can be stealth superspreaders of malaria to mosquitoeson November 18, 2020 at 8:45 am
Children infected with malaria can become "superspreaders" and pass the parasite to droves of local mosquitoes, even if the kids never develop symptoms of the disease, a new study suggests. Since this ...
- ‘Mosquito’ DP on Recreating Mental Effects of Malaria for Mozambique-Set Filmon November 17, 2020 at 2:23 pm
While making the period war film “Mosquito,” cinematographer Adolpho Veloso found himself at risk of losing more than great shots, he said, recalling the richly atmospheric locations in ...
via Bing News